| Aptean Launches Ascent, an Outcome-Based AI Partnership Built on Measurable Business Results |
Globe Newswire |
10/07 |
08:00 |
| Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development |
Globe Newswire |
10/07 |
08:00 |
| Erin Schaefer, Former Google/YouTube Senior Executive, Joins Roundtable Board to Help Guide Premium-Media OS Growth |
Globe Newswire |
10/07 |
08:00 |
| Madison Realty Capital Provides Loan for Hotel Washington in Washington, D.C. |
Globe Newswire |
10/07 |
08:00 |
| Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide |
Globe Newswire |
10/07 |
08:00 |
| Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live |
Globe Newswire |
10/07 |
08:00 |
| Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness |
Globe Newswire |
10/07 |
08:00 |
| Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home |
Globe Newswire |
10/07 |
08:00 |
| Nuclear Waste Innovator Deep Isolation to Present at Three Upcoming Investor Conferences |
Globe Newswire |
10/07 |
08:00 |
| Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis |
Globe Newswire |
10/07 |
08:00 |
| Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040 |
Globe Newswire |
10/07 |
08:00 |
| Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy |
Globe Newswire |
10/07 |
08:00 |
| Virtu Financial to Host Conference Call Announcing Third Quarter 2026 Results on Thursday, November 5, 2026 |
Globe Newswire |
10/07 |
08:00 |
| Bitcoin Learns to Move: IBVM Lists on MEXC as TOKEN2049 Comes to Singapore |
Globe Newswire |
10/07 |
07:55 |
| Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer |
Globe Newswire |
10/07 |
07:30 |
| Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets |
Globe Newswire |
10/07 |
07:30 |
| Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations |
Globe Newswire |
10/07 |
07:30 |
| Crane NXT Appoints Jeong H. Kim to Board of Directors |
Globe Newswire |
10/07 |
07:30 |
| Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator |
Globe Newswire |
10/07 |
07:05 |
| Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026 |
Globe Newswire |
10/07 |
07:05 |
| Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026 |
Globe Newswire |
10/07 |
07:05 |
| VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy |
Globe Newswire |
10/07 |
07:00 |
| BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds |
Globe Newswire |
10/07 |
07:00 |
| Noah Closes $38m Seed Funding Round as Major Enterprises Move Cross-Border Payments onto Stablecoin |
Globe Newswire |
10/07 |
07:00 |
| Badass Capital Fund I Reports 39.92% Net Return In Q3 2026 |
Globe Newswire |
10/07 |
07:00 |
